Doctor’s Passport

Find your next topic

Explore the current textbook

Available drafts · Clinical review pending
Membership
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
RapidMSRAMRCGP

Prescribing and medicines review in primary care

Essential points for quick revision.

Saved on this device

Synopsis

Prescribe and review medicines safely by confirming indication, benefit, patient use, monitoring, interactions and continued need across transitions of care.

  • Before prescribing, confirm identity, indication, allergies, pregnancy potential, relevant organ function, current medicines and enough clinical information for the decision.
  • Use the current BNF, SmPC and condition guideline for exact dose, route, frequency, duration, contraindications and monitoring; separate licensed product information from national recommendation.
  • A structured medication review is a shared, critical examination of all medicines to agree treatment, optimise benefit, minimise problems and reduce waste.

Reasoning priorities

01
Best possible medicines history

Establish actual current exposure and discrepancies.

Triangulate patient account, containers, repeat list, dispensing and clinical letters and resolve rather than merely list differences.

Worked reasoning

Worked case: discharge discrepanciesReconcile before repeating

A patient requests repeats after admission; the discharge list stops one medicine, halves another and adds a seven-day item, but old repeats remain active.

  1. Confirm what the patient has actually taken since discharge, current symptoms and urgent harm; compare hospital list, pre-admission record, pharmacy supply and available results.
  2. For every discrepancy establish whether change was intentional, why, duration, monitoring and responsible clinician; contact the hospital team when the rationale or safety is unclear.
  3. Complete the final action by updating active repeats, issuing only verified necessary supply, documenting reasons and communicating the reconciled list to patient, pharmacy and relevant care providers.
  4. Verify understanding with teach-back, arrange medicine-specific monitoring and expiry of the time-limited item, and review for disease control, adverse effects and unresolved specialist responsibility.
Open full textbook Answer 2 questions
Sources and review status4 sources · checked 7 Sept 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Apply principles in context and verify current guidance when a decision affects care. Source check completed 7 Sept 2026; clinical approval remains outstanding.

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom